Mykotische und bakterielle Infektionen

Julia Vaübel(University of Duisburg-Essen), Andreas Körber(Ruhrlandklinik), Dirk Schadendorf(National Center for Tumor Diseases), Lisa Huptas, Elvir Cesko(Essen University Hospital), Nadine Voshege, Thomas Jansen(Ruhr University Bochum), Sarah Piel(Düsseldorf University Hospital), Joachim Dissemond(Essen University Hospital)
hautnah dermatologie
July 1, 2010
10.1007/bf03358115
Cited by 0

Related Papers

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
|Science|2015|3k
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
|New England Journal of Medicine|2014|2.7k